RT @TumorBoardTues: 7/9 #TumorBoardTuesday Thurs Case🎀 We’re TBT…so we’re going to push the ✉️ ➡️🔬Pt tumor w EGFR amp. Actionable? @oncol…
RT @TumorBoardTues: 7/9 #TumorBoardTuesday Thurs Case🎀 We’re TBT…so we’re going to push the ✉️ ➡️🔬Pt tumor w EGFR amp. Actionable? @oncol…
RT @TumorBoardTues: 7/9 #TumorBoardTuesday Thurs Case🎀 We’re TBT…so we’re going to push the ✉️ ➡️🔬Pt tumor w EGFR amp. Actionable? @oncol…
RT @TumorBoardTues: 7/9 #TumorBoardTuesday Thurs Case🎀 We’re TBT…so we’re going to push the ✉️ ➡️🔬Pt tumor w EGFR amp. Actionable? @oncol…
7/9 #TumorBoardTuesday Thurs Case🎀 We’re TBT…so we’re going to push the ✉️ ➡️🔬Pt tumor w EGFR amp. Actionable? @oncologician points out- copy number matters. RR over 50% w anti-EGFR agent in pts with EGFR amp https://t.co/8XKjLYBgSw
RT @KlempnerSam: As @SteveMaronMD and @DocCatenacci have been saying since @CD_AACR (https://t.co/StmcHeWey3),EGFR is actionable in subset…
RT @KlempnerSam: As @SteveMaronMD and @DocCatenacci have been saying since @CD_AACR (https://t.co/StmcHeWey3),EGFR is actionable in subset…
RT @KlempnerSam: As @SteveMaronMD and @DocCatenacci have been saying since @CD_AACR (https://t.co/StmcHeWey3),EGFR is actionable in subset…
RT @OncoAlert: The #OncoAlertTopTweet 🚨Day 2⃣ #ESMO21 Tweet @klempersam EGFR is actionable in subset of #GEA Best, @weoncologists
RT @KlempnerSam: As @SteveMaronMD and @DocCatenacci have been saying since @CD_AACR (https://t.co/StmcHeWey3),EGFR is actionable in subset…
RT @OncoAlert: The #OncoAlertTopTweet 🚨Day 2⃣ #ESMO21 Tweet @klempersam EGFR is actionable in subset of #GEA Best, @weoncologists
RT @OncoAlert: The #OncoAlertTopTweet 🚨Day 2⃣ #ESMO21 Tweet @klempersam EGFR is actionable in subset of #GEA Best, @weoncologists
RT @RussellPetty19: It was a pleasure to work together with colleagues on this Global 🌍collaboration which further strengthens the evide…
RT @KlempnerSam: As @SteveMaronMD and @DocCatenacci have been saying since @CD_AACR (https://t.co/StmcHeWey3),EGFR is actionable in subset…
RT @OncoAlert: The #OncoAlertTopTweet 🚨Day 2⃣ #ESMO21 Tweet @klempersam EGFR is actionable in subset of #GEA Best, @weoncologists https…
The #OncoAlertTopTweet 🚨Day 2⃣ #ESMO21 Tweet @klempersam EGFR is actionable in subset of #GEA Best, @weoncologists
RT @pashtoonkasi: #ESMO21 📌5️⃣ 👇🏾One more actionable marker #EGFR amplification ⬆️⬆️⬆️ for #ESOCSM #STCSM #EsophagealCancer #StomachCancer…
RT @pashtoonkasi: #ESMO21 📌5️⃣ 👇🏾One more actionable marker #EGFR amplification ⬆️⬆️⬆️ for #ESOCSM #STCSM #EsophagealCancer #StomachCancer…
RT @pashtoonkasi: #ESMO21 📌5️⃣ 👇🏾One more actionable marker #EGFR amplification ⬆️⬆️⬆️ for #ESOCSM #STCSM #EsophagealCancer #StomachCancer…
RT @KlempnerSam: As @SteveMaronMD and @DocCatenacci have been saying since @CD_AACR (https://t.co/StmcHeWey3),EGFR is actionable in subset…
It was a pleasure to work together with colleagues on this Global 🌍collaboration which further strengthens the evidence for an actionable EGFR driven #GEA subset. EGFR inhibition in #GEA is ‘ back from the brink’ https://t.co/l2o3XDSe0f We need a pro
RT @KlempnerSam: As @SteveMaronMD and @DocCatenacci have been saying since @CD_AACR (https://t.co/StmcHeWey3),EGFR is actionable in subset…
RT @KlempnerSam: As @SteveMaronMD and @DocCatenacci have been saying since @CD_AACR (https://t.co/StmcHeWey3),EGFR is actionable in subset…
RT @KlempnerSam: As @SteveMaronMD and @DocCatenacci have been saying since @CD_AACR (https://t.co/StmcHeWey3),EGFR is actionable in subset…
RT @KlempnerSam: As @SteveMaronMD and @DocCatenacci have been saying since @CD_AACR (https://t.co/StmcHeWey3),EGFR is actionable in subset…
RT @KlempnerSam: As @SteveMaronMD and @DocCatenacci have been saying since @CD_AACR (https://t.co/StmcHeWey3),EGFR is actionable in subset…
RT @KlempnerSam: As @SteveMaronMD and @DocCatenacci have been saying since @CD_AACR (https://t.co/StmcHeWey3),EGFR is actionable in subset…
RT @KlempnerSam: As @SteveMaronMD and @DocCatenacci have been saying since @CD_AACR (https://t.co/StmcHeWey3),EGFR is actionable in subset…
RT @KlempnerSam: As @SteveMaronMD and @DocCatenacci have been saying since @CD_AACR (https://t.co/StmcHeWey3),EGFR is actionable in subset…
RT @KlempnerSam: As @SteveMaronMD and @DocCatenacci have been saying since @CD_AACR (https://t.co/StmcHeWey3),EGFR is actionable in subset…
RT @KlempnerSam: As @SteveMaronMD and @DocCatenacci have been saying since @CD_AACR (https://t.co/StmcHeWey3),EGFR is actionable in subset…
RT @pashtoonkasi: #ESMO21 📌5️⃣ 👇🏾One more actionable marker #EGFR amplification ⬆️⬆️⬆️ for #ESOCSM #STCSM #EsophagealCancer #StomachCancer…
RT @pashtoonkasi: #ESMO21 📌5️⃣ 👇🏾One more actionable marker #EGFR amplification ⬆️⬆️⬆️ for #ESOCSM #STCSM #EsophagealCancer #StomachCancer…
RT @KlempnerSam: As @SteveMaronMD and @DocCatenacci have been saying since @CD_AACR (https://t.co/StmcHeWey3),EGFR is actionable in subset…
#ESMO21 📌5️⃣ 👇🏾One more actionable marker #EGFR amplification ⬆️⬆️⬆️ for #ESOCSM #STCSM #EsophagealCancer #StomachCancer Thanks @SteveMaronMD for putting this great pooling of data collaboration together. Some pts benefit significantly. #PrecisionMedici
RT @KlempnerSam: As @SteveMaronMD and @DocCatenacci have been saying since @CD_AACR (https://t.co/StmcHeWey3),EGFR is actionable in subset…
RT @KlempnerSam: As @SteveMaronMD and @DocCatenacci have been saying since @CD_AACR (https://t.co/StmcHeWey3),EGFR is actionable in subset…
RT @KlempnerSam: As @SteveMaronMD and @DocCatenacci have been saying since @CD_AACR (https://t.co/StmcHeWey3),EGFR is actionable in subset…
As @SteveMaronMD and @DocCatenacci have been saying since @CD_AACR (https://t.co/StmcHeWey3),EGFR is actionable in subset of #GEA. #ESMO21 @myESMO @JoeChaoMD @pashtoonkasi @FilippoPietran4 @NataliyaUboha @RussellPetty19 @KoheiShitara @AnwaarSaeed3 @JeeyunM
RT @DocCatenacci: @Dr_R_Kurzrock It is definitely a viable target: Targeted Therapies for Targeted Populations: Anti-EGFR Treatment for EGF…
RT @DocCatenacci: @Dr_R_Kurzrock It is definitely a viable target: Targeted Therapies for Targeted Populations: Anti-EGFR Treatment for EGF…
RT @DocCatenacci: @Dr_R_Kurzrock It is definitely a viable target: Targeted Therapies for Targeted Populations: Anti-EGFR Treatment for EGF…
@Dr_R_Kurzrock It is definitely a viable target: Targeted Therapies for Targeted Populations: Anti-EGFR Treatment for EGFR-Amplified Gastroesophageal Adenocarcinoma https://t.co/3TXby3x9DP
@UmutDisel @oncologician @weldeiry @agrothey @KlempnerSam @VivekSubbiah @DrYukselUrun @DrChoueiri @GIcancerDoc @christine_lovly @abxka DOI: 10.1158/2159-8290.CD-17-1260 https://t.co/YUts0P7Y5Q
RT @mtmdphd: Targeted Therapies for Targeted Populations: Anti-EGFR Treatment for EGFR - Amplified Gastroesophageal Adenocarcinoma [Feb 15,…
Targeted Therapies for Targeted Populations: Anti-EGFR Treatment for EGFR - Amplified Gastroesophageal Adenocarcinoma [Feb 15, 2018] Maron et al. @CD_AACR https://t.co/W7Ykrwdkw4 #stcsm #esocsm #PrecisionMedicine
RT @AACR: Prospective EGFR inhibitor therapy achieved responses in 4 of 7 patients with EGFR-amplified gastroesophageal adenocarcinoma, Dan…
RT @AACR: Prospective EGFR inhibitor therapy achieved responses in 4 of 7 patients with EGFR-amplified gastroesophageal adenocarcinoma, Dan…
RT @AACR: Prospective EGFR inhibitor therapy achieved responses in 4 of 7 patients with EGFR-amplified gastroesophageal adenocarcinoma, Dan…
RT @AACR: Prospective EGFR inhibitor therapy achieved responses in 4 of 7 patients with EGFR-amplified gastroesophageal adenocarcinoma, Dan…
Prospective EGFR inhibitor therapy achieved responses in 4 of 7 patients with EGFR-amplified gastroesophageal adenocarcinoma, Daniel V. T. Catenacci, et al. https://t.co/Jbj39v3TmA https://t.co/xZkwTceRaU
Exciting new study from @DocCatenacci and team showing effectiveness of anti-EGFR treatment for EGFR-amplified gastroesophageal adenocarcinoma https://t.co/0RIgloSg2k
Targeted therapies for targeted populations: Anti-EGFR treatment for EGFR amplified gastroesophageal adenocarcinoma. https://t.co/NHlJPr0SSm https://t.co/78MRK250yC